Tag: Shukra Pharmaceuticals Limited

Synopsis: Several stocks under Rs. 100 reported extraordinary Q3FY26 EPS growth up to 1,900 percent, driven by strong revenue gains, sequential profit improvements, and robust earnings momentum, signaling major turnarounds…